DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for geroderma osteodysplastica — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleGeroderma osteodysplastica maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for geroderma osteodysplastica is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
Geroderma osteodysplastica is an autosomal recessive connective tissue disorder caused by loss-of-function mutations in GORAB on chromosome 1q24. A 2008 autozygosity mapping study in one Libyan and four consanguineous Pakistani families with ten affected individuals defined a 4 Mb homozygous region on 1q24 and confirmed the disorder is not allelic to wrinkly skin syndrome caused by ATP6V0A2 mutations. A 2021 case report described a young male patient from related Saudi parents with a homozygous frameshift mutation (c.306dup, p.Pro103Thrfs*20) and noted atypical features including tall stature and arachnodactyly, whereas most previously reported cases had short stature.
A 2024 case report described a cyanotic female neonate with transposition of great vessels corrected by surgery, who also had wrinkled skin and joint hyperlaxity. Genetic testing revealed two novel compound heterozygous GORAB mutations (p.Asp236* and p.Asp236Ala). The patient was started on bisphosphonates, which the authors state led to a reduction in the occurrence of fractures. This is the first reported concurrent incidence of geroderma osteodysplastica with transposition of great vessels.
The disorder is characterised by wrinkled lax skin, joint laxity, osteoporosis, frequent fractures, scoliosis, bowed long bones, vertebral collapse, and hyperextensible fingers. Whole exome sequencing is described as the gold standard for diagnosis. The 2024 authors recommend early diagnosis to prevent or reduce bone density loss via bisphosphonate treatment, but the evidence for this intervention remains limited to a single case report with no controlled data.
What is still missing are prospective studies with adequate sample sizes, standardised outcome measures for bone density and fracture rates, and any randomised trial of bisphosphonates or other treatments in this population. The natural history of the disorder, particularly the long-term effect of bisphosphonate therapy and the significance of the reported cardiac anomaly, remains poorly characterised.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
American Journal of Medical Genetics Part A · 2008 · 13 citations
Geroderma osteodysplastica maps to a 4 Mb locus on chromosome 1q24
AbstractImportant insights into the etiology of osteoporosis have been gained by the study of single gene disorders, including osteogenesis imperfecta. We report on the genetic mapping of geroderma osteodysplastica (GO), a rare autosomal recessive disorder of the connective tissue, characterized by wrinkly skin and severe osteoporosis. We undertook autozygosity mapping in one Libyan and four consanguineous Pakistani families with a total of 10 affected individuals to define a 4 Mb homozygous region on chromosome 1q24, which harbors the GO causative gene. No obvious candidate genes that encode known protein constituents of the extracellular matrix are found in the linked region. Importantly, our study demonstrates that GO is not allelic to wrinkly skin syndrome caused by mutations in ATP6V0A2.
Case Reports in Genetics · 2024 · 1 citations · open access
Geroderma Osteodysplastica With Concomitant Transposition of Great Vessels: A Case Report and Literature Review
AbstractGeroderma Osteodysplastica (GO) is a rare autosomal recessive connective tissue disease characterized by wrinkled skin and osteoporosis, two distinct aging‐related features. A loss of function mutation in GORAB results in the disease. Immediately after birth, a cyanotic female neonate was found to have transposition of great vessels (TGV) that was corrected with an uneventful surgical recovery. The patient was noted to have wrinkled skin and hyperlaxity in her joints. After a complete nutritional and metabolic panel, in addition to karyotyping, imaging, skin histopathology analysis, and genetic testing she was found to have GO. We found two novel compound heterozygous mutations in GORAB : p.Asp236∗ and pAsp236Ala. This is the first study that reports the concurrent incidence of GO with TGV. The patient was started on bisphosphonates, which led to a reduction in the occurrence of fractures. An early diagnosis of GO is warranted to prevent or reduce bone density loss due to osteoporosis via initiation of bisphosphonate treatment. Whole exome sequencing remains the gold standard for diagnosing GO and ruling out phenotypically similar disorders.
Journal of Clinical Research and Reports · 2021 · 1 citations · open access
A Case of Geroderma Osteodysplasticum Syndrome: Unique Clinical Findings
AbstractGeroderma osteodysplasticum (GO; MIM 231070) is characterized by a typical progeroid facial appearance, wrinkled, lax skin, joint laxity, skeletal abnormalities with variable degree of osteopenia, frequent fractures, scoliosis, bowed long bones, vertebral collapse, and hyperextensible fingers. The disorder results from mutations in the GORAB - golgin, RAB6 interacting. This gene encodes a member of the golgin family, a group of coiled-coil proteins on golgin. That maps to chromosome 1q24. The encoded protein has a function in the secretory pathway. Was identified by-teIrminal kinase-like protein, and thus it may function in mitosis? Mutations in this gene have been associated with geroderma osteodysplastica. Herein, we describe the clinical presentation of one young male patient from related Saudi parents. mutations, a homozygous Frameshift mutation (c.306dup p.(pro 103 Thrfs*20). Interestingly, phenotypic variability was observed in this patient with GO features that were atypical than the cases reported in the literature. As he looks tall stature where the most of cases reported were short and arachnodactyly of fingers which mimic and other syndromes.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
